Clinical Study
Clinical and Radiographic Outcomes with a Hydroxyapatite and Porous Coated Cup Design
Table 1
Published data on outcomes of similar cementless primary THAs.
| Manuscript | Implant used | Number of hips | Mean age | Mean Followup (years) | Revision (acetabular aseptic loosening) | Revision (all cause) | Dislocation | Osteolysis |
| Anseth et al. (2010) [18] | Harris-Galante I/II | 113 | 54 | 17.2 | 2 (1.8%) | 4 (3.5%) | NR | 2 (1.8%) | Baker et al. (2010) [19] | ABG I | 69 | 53 | 15 | 8 (11.6%) | 8 (11.6%) | 0 | 10 (14.5%) | Belmont et al. (2008) [12] | Trispike (DePuy) | 223 | 71.8 | 20 | 9 (4%) | 26 (11.7%) | 1 (0.45%) | 17 (7.6%) | Della Valle et al. (2009) [13] | Harris-Galante I | 204 | 52 | 20.6 | 5 (4%) | 10 (8.1%) | 5/124 | NR | Chen et al. (2006) [20] | Duraloc | 145 | 56.2 | 6.7 | 0 (0%) | 2 (1.4%) | 9/148 (6.1%) | 3 (2%) | Streit et al. (2012) [21] | Fitmore | 89 | 49 | 12 | 0 (0%) | 5/81, 2 liner exchange | 1/81 | 0 (0%) | Berli et al. (2007) [22] | Morscher | 112 | | 14.7 | 2.5% | 4.7% | | | Della Valle et al. (2004) [23] | Trilogy | 308 | 64 | 4–7 | 1 (0.3%) | 8 (2.4%) | NR | 12 (5%) | Sugano et al. (2012) [24] | Biolox forte | 93 | 56 | 12.4 | 1 (1.1%) | 2 (2.2%) ? (cup only) | 1 (1.1%) | 0 (0%) | de Witte et al. (2011) [25] | CementLess Spotorno | 102 | 55.9 | 11.8 | 9 (8.8%) | 10 (cup) | NR | NR | Stefl et al. (2012) [26] | Harris-Galante I | 120 | NR | 23.3 | 1 (0.8%) | 22 (18.3%) | NR | 8 (6.7%) | Gottliebsen et al. (2012) [27] | Mallory-Head | 77 HA coated 73 non-HA coated | 57 (HA) 63 (non-HA) | 11 | HA coated: 0 (0%) Non-HA coated: 7 (9.6%) | HA coated: 0% Non-HA: 9.6% | NR | NR |
|
|